Analyst Price Target is $90.50
▲ +27.45% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for AtriCure in the last 3 months. The average price target is $90.50, with a high forecast of $120.00 and a low forecast of $75.00. The average price target represents a 27.45% upside from the last price of $71.01.
Current Consensus is
The current consensus among 8 contributing investment analysts is to buy stock in AtriCure. This Buy consensus rating has held steady for over two years.
AtriCure, Inc. engages in the development, manufacture, and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in Mason, OH.